OLMESARTAN Side Effects

5252074-6 | Cardio-respiratory Arrest, Hyperglycaemia, Renal Impairment
on Feb 14, 2007 Male patient from SPAIN , 66 years of age, was diagnosed with renal failure and was treated with Olmesartan (View Usage). Patient experienced the following unwanted or unexpected effects: cardio-respiratory arrest, hyperglycaemia, renal impairment. Olmesartan dosage: 20 Mg Qd Po. During the same period patient was treated with AVANDIA (View Avandia Review and Avandia Label ), DIGOXIN (View Digoxin Review and Digoxin Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), SECALIP (View Secalip Review and Secalip Label ), RESINCALCIO (View Resincalcio Review and Resincalcio Label ), VITALUX (View Vitalux Review and Vitalux Label ). Patient was hospitalized.

5026894-7 | Blood Pressure Decreased
Patient was taking Olmesartan (View Usage). Patient had the following side effects: blood pressure decreased on May 25, 2006 from BRAZIL Additional patient health information: Female patient , 52 years of age, was diagnosed with hypertension and. Olmesartan dosage: 20 Mg Qd Po. During the same period patient was treated with ALENIA (View Alenia Review and Alenia Label ).

4979099-X | Nephrolithiasis
Adverse event was reported on Apr 11, 2006 by a Male patient taking Olmesartan (View Usage) (Dosage: 20 Mg Qd Po) was diagnosed with hypertension and. Location: UNITED KINGDOM , 45 years of age, weighting 207.2 lb, After Olmesartan was administered, patient had the following side effects: nephrolithiasis. Patient was hospitalized.

4958087-3 | Myocardial Infarction
on Mar 15, 2006 Male patient from BRAZIL , 61 years of age, was diagnosed with hypertension and was treated with Olmesartan (View Usage). Patient experienced the following unwanted or unexpected effects: myocardial infarction. Olmesartan dosage: 20 Mg Qd Po. During the same period patient was treated with PROPOLUS (View Propolus Review and Propolus Label ).


4943846-3 | Nephrolithiasis
on Feb 28, 2006 Male patient from UNITED KINGDOM , 45 years of age, weighting 207.2 lb, was diagnosed with hypertension and was treated with Olmesartan (View Usage). Patient had the following side effects: nephrolithiasis. Olmesartan dosage: 20 Mg Qd Po.

4938523-9 | Cerebral Infarction, Memory Impairment
Patient was taking Olmesartan (View Usage). After Olmesartan was administered, patient had the following side effects: cerebral infarction, memory impairment on Feb 16, 2006 from JAPAN Additional patient health information: Male patient , 66 years of age, weighting 119.7 lb, was diagnosed with diabetes mellitus non-insulin-dependent, diabetic nephropathy and. Olmesartan dosage: 10 Mg Qd Po.

4934248-4 | Cerebral Infarction, Cerebrovascular Accident, Orthostatic Hypotension, Refusal Of Treatment By Patient, Transient Ischaemic Attack
Adverse event was reported on Feb 20, 2006 by a Male patient taking Olmesartan (View Usage) (Dosage: 10 Mg Qd Po) was diagnosed with diabetes mellitus non-insulin-dependent, diabetic nephropathy and. Location: JAPAN , 58 years of age, weighting 138.0 lb, Patient experienced the following unwanted or unexpected effects: cerebral infarction, cerebrovascular accident, orthostatic hypotension, refusal of treatment by patient, transient ischaemic attack.

4930146-0 | Hyperkalaemia
on Feb 13, 2006 Female patient from HONG KONG , 60 years of age, weighting 140.0 lb, was diagnosed with diabetes mellitus non-insulin-dependent, diabetic nephropathy and was treated with Olmesartan (View Usage). Patient had the following side effects: hyperkalaemia. Olmesartan dosage: 10 Mg Qd Po. Patient was hospitalized.

4920138-X | Cerebral Infarction, Cerebrovascular Disorder, Orthostatic Hypotension
on Feb 06, 2006 Male patient from JAPAN , 58 years of age, weighting 138.0 lb, was diagnosed with diabetic nephropathy, hypertension and was treated with Olmesartan (View Usage). After Olmesartan was administered, patient had the following side effects: cerebral infarction, cerebrovascular disorder, orthostatic hypotension. Olmesartan dosage: 10 Mg Qd Po. During the same period patient was treated with NORVASC (2.5 Mg Qd Po) (View Norvasc Review and Norvasc Label ).

4903365-7 | Dizziness, Nausea, Oral Intake Reduced, Renal Failure Acute, Renal Tubular Acidosis, Vision Blurred
Patient was taking Olmesartan (View Usage). Patient experienced the following unwanted or unexpected effects: dizziness (What is dizziness?), nausea (What is nausea?), oral intake reduced, renal failure acute, renal tubular acidosis, vision blurred on Feb 06, 2006 from UNITED STATES Additional patient health information: Male patient , 66 years of age, . Olmesartan dosage: 20 Mg Daily Po. During the same period patient was treated with TACROLIMUS (View Tacrolimus Review and Tacrolimus Label ), NEURONTIN (View Neurontin Review and Neurontin Label ), ZANTAC (View Zantac Review and Zantac Label ), LEXAPRO (View Lexapro Review and Lexapro Label ), INSULIN (View Insulin Review and Insulin Label ), URSODIOL (View Ursodiol Review and Ursodiol Label ), DITROPAN (View Ditropan Review and Ditropan Label ), CIPRO (View Cipro Review and Cipro Label ). Patient was hospitalized.

4819849-6 | Acute Myocardial Infarction, Atrioventricular Block Complete, Cardiac Arrest, Cardiogenic Shock, Dialysis, Metabolic Acidosis, Nausea, Pulmonary Oedema, Renal Failure Acute
Adverse event was reported on Oct 26, 2005 by a Male patient taking Olmesartan (View Usage) (Dosage: Mg Po) was diagnosed with hypertension and. Location: ISRAEL , 58 years of age, Patient had the following side effects: acute myocardial infarction, atrioventricular block complete, cardiac arrest (What is cardiac arrest?), cardiogenic shock, dialysis (What is dialysis?), metabolic acidosis, nausea (What is nausea?), pulmonary oedema, renal failure acute. During the same period patient was treated with LITHIUM (View Lithium Review and Lithium Label ), OSCAAR (View Oscaar Review and Oscaar Label ). Patient was hospitalized.

4788467-0 | Contusion, Dizziness, Excoriation, Face Injury, Fall, Head Injury, Loss Of Consciousness
on Oct 05, 2005 Female patient from UNITED STATES , 77 years of age, was diagnosed with hypertension and was treated with Olmesartan (View Usage). After Olmesartan was administered, patient had the following side effects: contusion, dizziness (What is dizziness?), excoriation, face injury, fall (What is fall?), head injury, loss of consciousness. Olmesartan dosage: 30 Mg Po Qd. During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), ATORVASTATIN (View Atorvastatin Review and Atorvastatin Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ), NEXIUM (View Nexium Review and Nexium Label ). Patient was hospitalized.

4781536-0 | Blood Creatinine Increased, Cataract, Hyperkalaemia
on Sep 05, 2005 Male patient from HONG KONG , 40 years of age, was diagnosed with diabetes mellitus non-insulin-dependent, diabetic nephropathy, hypertension and was treated with Olmesartan (View Usage). Patient experienced the following unwanted or unexpected effects: blood creatinine increased, cataract (What is cataract?), hyperkalaemia. Olmesartan dosage: 10 Mg Qd Po. During the same period patient was treated with ACERTIL (4 Mg Qd Po) (View Acertil Review and Acertil Label ), PROTAPHANE MC (View Protaphane Mc Review and Protaphane Mc Label ), LESCOL XL (View Lescol Xl Review and Lescol Xl Label ), ADALAT (View Adalat Review and Adalat Label ). Patient was hospitalized.

4778940-3 | Cerebral Infarction
Patient was taking Olmesartan (View Usage). Patient had the following side effects: cerebral infarction on Sep 01, 2005 from JAPAN Additional patient health information: Male patient , 66 years of age, was diagnosed with diabetes mellitus non-insulin-dependent, diabetic nephropathy and. Olmesartan dosage: 10 Mg Qd Po.

4764430-0 | Hyperkalaemia
Adverse event was reported on Aug 24, 2005 by a Male patient taking Olmesartan (View Usage) (Dosage: 10 Mg Qd Po) was diagnosed with diabetes mellitus non-insulin-dependent, diabetic nephropathy, hypertension and. Location: HONG KONG , 40 years of age, After Olmesartan was administered, patient had the following side effects: hyperkalaemia. During the same period patient was treated with ACETRIL (4 Mg Qd Po) (View Acetril Review and Acetril Label ), PROTAPHANE MC (View Protaphane Mc Review and Protaphane Mc Label ), LESCOL XL (View Lescol Xl Review and Lescol Xl Label ), ADALAT (View Adalat Review and Adalat Label ). Patient was hospitalized.

4760286-0 | Acute Myocardial Infarction, Atrioventricular Block Complete, Blood Lactic Acid Increased, Blood Potassium Increased, Cardiac Arrest, Cardiogenic Shock, Coronary Artery Occlusion, Pulmonary Oedema, Renal Failure Acute
on Aug 25, 2005 Male patient from ISRAEL , 58 years of age, was diagnosed with hypertension and was treated with Olmesartan (View Usage). Patient experienced the following unwanted or unexpected effects: acute myocardial infarction, atrioventricular block complete, blood lactic acid increased, blood potassium increased, cardiac arrest (What is cardiac arrest?), cardiogenic shock, coronary artery occlusion, pulmonary oedema, renal failure acute. Olmesartan dosage: Po. During the same period patient was treated with LITHIUM CARBONATE (View Lithium Carbonate Review and Lithium Carbonate Label ). Patient was hospitalized.

4754580-7 | Acute Myocardial Infarction, Atrioventricular Block Complete, Blood Lactic Acid Increased, Blood Potassium Increased, Cardiac Arrest, Cardiac Procedure Complication, Cardiogenic Shock, Coronary Artery Occlusion, Dialysis
on Aug 21, 2005 Male patient from ISRAEL , 58 years of age, was diagnosed with hypertension and was treated with Olmesartan (View Usage). Patient had the following side effects: acute myocardial infarction, atrioventricular block complete, blood lactic acid increased, blood potassium increased, cardiac arrest (What is cardiac arrest?), cardiac procedure complication, cardiogenic shock, coronary artery occlusion, dialysis (What is dialysis?). Olmesartan dosage: Mg Po. During the same period patient was treated with LITHIUM CARBONATE (View Lithium Carbonate Review and Lithium Carbonate Label ). Patient was hospitalized.

4753594-0 | Acute Myocardial Infarction, Blood Creatinine Increased, Blood Lactic Acid Increased, Cardiac Arrest, Cardiogenic Shock, Coronary Artery Occlusion, Dyspnoea, Pulmonary Oedema
Patient was taking Olmesartan (View Usage). After Olmesartan was administered, patient had the following side effects: acute myocardial infarction, blood creatinine increased, blood lactic acid increased, cardiac arrest (What is cardiac arrest?), cardiogenic shock, coronary artery occlusion, dyspnoea, pulmonary oedema on Aug 18, 2005 from ISRAEL Additional patient health information: Male patient , 58 years of age, was diagnosed with hypertension and. Olmesartan dosage: Mg Po. During the same period patient was treated with LITHIUM CARBONATE (View Lithium Carbonate Review and Lithium Carbonate Label ). Patient was hospitalized.

4751750-9 | Blood Pressure Systolic Increased, Fall, Orthostatic Hypotension
Adverse event was reported on Aug 11, 2005 by a Female patient taking Olmesartan (View Usage) (Dosage: 10 Mg Qd Po) was diagnosed with hypertension and. Location: UNITED KINGDOM , 74 years of age, weighting 112.4 lb, Patient experienced the following unwanted or unexpected effects: blood pressure systolic increased, fall (What is fall?), orthostatic hypotension. During the same period patient was treated with BECLOMETHASONE AQUEOUS (View Beclomethasone Aqueous Review and Beclomethasone Aqueous Label ), FYBOGEL (View Fybogel Review and Fybogel Label ), ASPIRIN (View Aspirin Review and Aspirin Label ). Patient was hospitalized.

4750380-2 | Hyperkalaemia, Renal Disorder, Renal Impairment, Sinus Bradycardia, Ultrasound Abdomen Abnormal
on Aug 04, 2005 Male patient from HONG KONG , 64 years of age, was diagnosed with diabetic nephropathy and was treated with Olmesartan (View Usage). Patient had the following side effects: hyperkalaemia, renal disorder, renal impairment, sinus bradycardia, ultrasound abdomen abnormal. Olmesartan dosage: 10 Mg Qd Po. During the same period patient was treated with LASIX (View Lasix Review and Lasix Label ), ADALAT (View Adalat Review and Adalat Label ). Patient was hospitalized.

4745632-6 | Orthostatic Hypotension
on Jul 27, 2005 Male patient from HONG KONG , 67 years of age, was diagnosed with diabetes mellitus non-insulin-dependent, diabetic nephropathy and was treated with Olmesartan (View Usage). After Olmesartan was administered, patient had the following side effects: orthostatic hypotension. Olmesartan dosage: 10 Mg Qd Po. Patient was hospitalized.

4699438-7 | Contusion, Purpura
Patient was taking Olmesartan (View Usage). Patient experienced the following unwanted or unexpected effects: contusion, purpura on Jun 14, 2005 from Additional patient health information: Female patient , 42 years of age, was diagnosed with hypertension, myocardial infarction, prophylaxis and. Olmesartan dosage: 20 Mg Qd Po. During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), CALCIUM GLUCONATE (View Calcium Gluconate Review and Calcium Gluconate Label ), RALOXIFENE HCL (View Raloxifene Hcl Review and Raloxifene Hcl Label ). Patient was hospitalized.

4691134-5 | Epistaxis
Adverse event was reported on Jun 02, 2005 by a Male patient taking Olmesartan (View Usage) (Dosage: 80 Mg Qd Po) was diagnosed with hypertension and. Location: , 37 years of age, weighting 143.3 lb, Patient had the following side effects: epistaxis. During the same period patient was treated with DOXAZOSIN (View Doxazosin Review and Doxazosin Label ), BETA BLOCKERS NOS (View Beta Blockers Nos Review and Beta Blockers Nos Label ), ANTIDIABETICS (View Antidiabetics Review and Antidiabetics Label ), ANTICALCIUM (View Anticalcium Review and Anticalcium Label ).

4619914-2 | Cardio-respiratory Arrest, Coma, Haematemesis, Haemodialysis, Oesophagitis Haemorrhagic, Renal Failure Acute
on Mar 21, 2005 Female patient from , 77 years of age, weighting 268.0 lb, was diagnosed with hypertension, breast cancer (What is breast cancer?) and was treated with Olmesartan (View Usage). After Olmesartan was administered, patient had the following side effects: cardio-respiratory arrest, coma, haematemesis, haemodialysis, oesophagitis haemorrhagic, renal failure acute. Olmesartan dosage: . During the same period patient was treated with EXEMESTANE (View Exemestane Review and Exemestane Label ), THEOPHYLLINE (View Theophylline Review and Theophylline Label ), HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), ADVAIR DISKUS 100/50 (View Advair Diskus 100/50 Review and Advair Diskus 100/50 Label ), ALBUTEROL (View Albuterol Review and Albuterol Label ), TYLENOL (CAPLET) (View Tylenol (caplet) Review and Tylenol (caplet) Label ).

4560642-X | Blood Pressure Increased, Epistaxis, Rash
on Jan 13, 2005 Female patient from , 70 years of age, was diagnosed with hypertension and was treated with Olmesartan (View Usage). Patient experienced the following unwanted or unexpected effects: blood pressure increased, epistaxis, rash (What is rash?). Olmesartan dosage: 20 Mg Qd Po. During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ). Patient was hospitalized.